Poland· PL-100362728
Canephron N
A medicinal product containing produkt ziołowy, registered in Poland by Bionorica SE.
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- Produkt ziołowy
- Manufacturer
- Bionorica SE
- Country
- Poland (PL)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
- gtin05909991306816
- gtin05909991306823
- gtin04029799168100
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fbc6cbbc-49ad-4fee-a18a-c0763e9c69cf GET /v1/drugs/fbc6cbbc-49ad-4fee-a18a-c0763e9c69cf?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Krople doustne, płyn",
"source": "urpl",
"strength": null,
"packaging": "05909991306816 ¦ OTC ¦ Skasowane ¦ 119160\n1 butelka 100 ml\n05909991306823 ¦ OTC ¦ 119161\n1 butelka 50 ml\n04029799168100 ¦ OTC ¦ 121548\n1 butelka 100 ml",
"substance": "Extractum compositum (1:56) ex: Levistici radice, Centauri herba, Rosmarini folio (1:1:1) 100 ml",
"common_name": "Produkt ziołowy",
"pl_product_id": "100362728",
"pozwolenie_nr": "23602",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about produkt ziołowy.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.